Mumbai: Wockhardt has announced that it has been informed by the European Medicines Agency (EMA) that WCK 5222, a combination ...
The European Medicines Agency (EMA) has informed Wockhardt that WCK 5222 (combination of Zidebactam 1g + Cefepime 2g) is eligible for Accelerated Assessment, following a pre-submission meeting with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback